Delivery Order SPE2DR25D2010-SPE2DR26F4ZSL
- Not listed
- The Defense Logistics Agency (DLA) awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This non-set-aside, competitively awarded contract operates on a firm fixed price basis with an ultimate completion date of January 12, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, valued at $14,592.57 for the supply of Vyndamax 61 mg capsule unit dose 30-count packages. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. This competitive award, issued on December 18, 2025, is scheduled for completion by January 12, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of December 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for supply of Vyndamax 61 mg capsule unit dose packages (30-count). This is a firm fixed price, non-set-aside contract with a completion deadline of August 26, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on November 20, 2025, with completion scheduled for December 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Vyndamax 61 mg capsules (30-count unit dose packaging). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and does not utilize a set-aside designation, indicating the award was made through full and open competition. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $14,592.57 on December 2, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. The contract is non-competitive and carries a firm fixed price structure with an ultimate completion date of December 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on December 2, 2025, with completion targeted for December 23, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026, with an ultimate completion date of January 26, 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZSLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,592.57 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of February 6, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains and supply a diverse customer base including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 1/14/26 |